ARCHIVES

Drugs and Targets: Cyramza approved in metastatic stomach cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 42 | November 7, 2014

Download PDF Visit The Full Archive

Related Articles

Society Recognizes Community Oncologists (8-page issue).

June 6, 2003

Clearinghouse Completes Review of Backlog, Funds What Caused It, Reports On Program Value

May 19, 1978

NCI Drops Protocol Review Requirement To Encourage firs To List Trials On PDQ

October 24, 1997

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011

DCT Board Offers Philosophical, Some Financial Aid to Program Projects, Says They Are “Irreplaceable”

June 18, 1982

Phase III Lung and Pancreatic Cancer Trials Are Stopped

April 30, 2010